Guide
1
«Tamoxifen" indicated for the treatment of cancer: breast cancer, and breast cancer, ovarian cancer, prostate, endometrial, melanoma, sarcoma, cancer of the kidney.The drug inhibits the synthesis of tumor tissue, cell hypertrophy stops, slows down the process of tumor formation.It is used after the diagnostic tests, which include a blood test, the definition of indicators of the level of hemoglobin and cholesterol, gynecological diagnostics, check status, liver function and kidney function.
2
daily dosage of the drug depends on the evidence.In breast cancer, take 20-40 mg once or twice a day, with endometrial cancer - 20-30 mg once or twice a day.The maximum daily amount is 40 milligrams.Pills "Tamoxifen" are inside, and washed down with plenty of water.Course duration lasts from one to t
hree months.Generally, treatment is carried out in combination with radiation therapy and drugs inhibiting tumor cell division.
3
«Tamoxifen" has the following side effects: nausea, vomiting, loss of appetite, diarrhea, dyspepsia, infiltration of the liver, cholestasis, increased body weight, anemia, thrombosis, leukopenia, drowsiness, confusion, fainting,dizziness, headache, uterine bleeding, cystic swelling, itching and burning genitals, painful vaginal discharge decreased potency, fever, hives, skin rash, redness of the skin, bronchospasm, alopecia, dermatitis.
4
«Tamoxifen" is contraindicated in detecting hypersensitivity to the drug, during pregnancy and breastfeeding, while leukopenia, cataract, thrombophlebitis, liver and kidney failure, cardiovascular disease in severe stages.With careful preparation is used in diseases of the brain, thrombocytosis, thrombocytopenia, hypercalcemia in patients with hyperlipidemia, cataract, leukopenia.During the period of treatment is not recommended to perform work requiring high concentration and speed of psychomotor reactions.In the process of receiving the funds need regular monitoring of peripheral blood picture, glucose or calcium in the blood, prolonged use is necessary every three months to be observed by an ophthalmologist.